Related Experiment Video
Updated: Jul 6, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
A case of appropriate inappropriate device therapy: hyperkalemia-induced ventricular oversensing
Gavin Y Oudit1, Doug Cameron, Louise Harris
1Division of Cardiology, Toronto General Hospital, University of Toronto, Ontario. gavin.oudit@utoronto.ca
Abstract:
The present case describes a patient who received inappropriate, but potentially life-saving, therapy from her implantable cardioverter defibrillator (ICD) in the setting of acute hyperkalemia (plasma potassium concentration = 8 mM). Hyperkalemia was associated with the development of a slow sinusoidal ventricular tachycardia, at a rate of 100 beats/min to 125 beats/min (610 ms to 480 ms) in a patient who is pacemaker-dependent. There was associated fractionation of the ICD electrogram and T wave oversensing, leading to ventricular oversensing with resultant detection in the ventricular fibrillation rate zone. This was followed by shock therapy, even though the ventricular tachycardia rate was below the programmed detection rate of the ICD. The subsequent emergency treatment of the hyperkalemia normalized the electrogram, corrected the ventricular oversensing and arrhythmia, and restored rate-adaptive single-chamber ventricular pacing.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antihypertensive Drugs: Potassium-Sparing Diuretics
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents

